None listed
Conditions
Interventions
None listed
Sponsors
SHISEIDO CO., LTD.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Those who are willing to participate in the study. (1) Those who have expressed their willingness to participate in the study, have understood the explanation, and have given written consent to participate in the study. (2) Healthy Japanese women between the ages of 35 and 45 who do not violate the exclusion criteria. (2) Healthy Japanese females between the ages of 35 and 45 who do not violate the exclusion criteria (3) No significant skin irritation, scars, or sunburn on the cheeks or upper arms (4) Regular meals (3 meals a day) for 3 days prior to the test, including the day of the test. (5) Refrain from drinking alcohol the day before and the day of urine collection. (6) Refrain from using supplements (including nutritional drinks) and medicines for 3 months before the test. (7) Those who can consent to urine and blood collection. (8) Those who can consent to the collection of stratum corneum tape from the cheek and upper arm. (9) Those who are able to fill out the consent form, questionnaire, and daily log.
Exclusion criteria
Exclusion criteria: (1) Those who are currently using skin beautifying and dieting supplements, collagen supplements, and medicines (including hyrdids and zinc ointments). (2) Those who are undergoing hospital visits or medication. (3) Those who have chronic diseases such as cancer, high blood pressure, diabetes, kidney failure, etc. (4) Those who have food allergies (5) Those who smoke on a daily basis (6) Those who are pregnant or planning to become pregnant, and those who are breast-feeding (7) Those who are currently participating in a study in which other foods or drugs are ingested or cosmetics or drugs are applied. Those who have participated in beauty treatments within the past three months. (8) Those with a history of visiting a cosmetic dermatologist within the past three months (9) Those who are scheduled to receive a new coronavirus vaccine within one week prior to the study. (10) Others who are judged as inappropriate by the principal investigator or the physician in charge of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| image data biological components VAS questionnaire BDHQ | — |
Countries
Japan
Contacts
Public ContactKanako Sakurai
Inforward, Inc Ebisu Skin Research Center
Outcome results
None listed